Osteoporosis Quality Use of Medicines Program

In December 2018, Kos designed, developed, and implemented the Osteoporosis Quality Use of Medicines Program with Amgen Australia. This PharmaPrograms initiative is a single intervention targeted at improving adherence rates among patients prescribed any antiresorptive medication.